Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This randomized, double-blind, placebo-controlled multi-center study will carry out to assess the efficacy of GB-0998 in the treatment of the systemic sclerosis based on the changes in modified Rodnan total skin thickness score (TSS) as primary endopoint, and in addition, to assess the safety of GB-0998.
Epistemonikos ID: 1c370d0683c7fab75349287986e75e2e5e605f3c
First added on: May 04, 2024